You are here: Industry Insights > COVID-19

News List

Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19 prnewswire
September 18, 2020
Early findings from researchers at Children's Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Ampio announces enrolment completion for intravenous Covid-19 clinical trial pharmaceutical-business-review
September 18, 2020
Ampio Pharmaceuticals, a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions announces the following ...
TridentCare to Provide COVID-19 Testing prnewswire
September 17, 2020
TridentCare, the largest portable diagnostic company in the United States serving multiple healthcare and commercial markets, announces support of Adventist Health and the El Concilio Community with on-site COVID-19 testing.
Designed antiviral proteins inhibit SARS-CoV-2 in the lab worldpharmanews
September 17, 2020
Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.
Progress toward antiviral treatments for COVID-19 worldpharmanews
September 17, 2020
COVID-19 is caused by a virus known as SARS-CoV-2, which is similar in structure to two other viruses that have caused recent outbreaks: SARS-CoV, which caused an outbreak of SARS in 2003, and MERS-CoV, the cause of a 2012 outbreak of ...
HiFiBiO, ABL Bio to co-develop HFB30132A antibody for Covid-19 pharmaceutical-business-review
September 17, 2020
HiFiBiO Therapeutics has entered into a partnership with South Korea-based ABL Bio to co-develop its SARS-CoV-2 neutralising antibody HFB30132A for the treatment of Covid-19.
NICE unites with global health leaders to highlight evidence-based healthcare pharmatimes
September 17, 2020
The UK’s National Institute for Health and Care Excellence (NICE) has joined a global initiative focused on bringing evidence-based healthcare to the fore worldwide.
Sleep apnoea linked to poorer outcomes from COVID-19, study finds pharmatimes
September 17, 2020
A systematic review of studies by researchers at the University of Warwick has found that people who have been diagnosed with obstructive sleep apnoea could be at an increased risk of adverse outcomes from COVID-19.
Phase III trial to study REGN-COV2, potential COVID-19 antibody treatment europeanpharmaceuticalreview
September 17, 2020
REGN-COV2 will be evaluated alongside standard-of-care in a Phase III study as part of the COVID-19 RECOVERY trial.
US researchers identify tiny molecule to neutralise Covid-19 virus pharmaceutical-technology
September 17, 2020
A research team at the University of Pittsburgh School of Medicine in the US has isolated a tiny biological molecule that could completely neutralise SARS-CoV-2, the virus that causes Covid-19.